EPLERENONE

Eplerenone is a selective aldosterone antagonist improving cardiac outcomes in heart failure. Side effects include hyperkalemia, dizziness, and renal impairment.

SKU: 99fb88d6abf0 Category: Tag:

Product Description


Mechanism of Action

Eplerenone is a selective mineralocorticoid receptor (MR) antagonist that blocks aldosterone‑mediated sodium retention, potassium excretion and cardiovascular fibrosis. More selective than spironolactone, it avoids androgen/progesterone receptor cross‑reactivity.

Benefits and Advantages

Used in aldosterone‑pathway modelling, MR‑signalling research, cardiac‑remodelling studies, and renal‑electrolyte regulation assays.

Side Effects and Risks

Risks include hyperkalemia, hypotension, dizziness and renal impairment. Handle with MR‑antagonist precautions.

Datasheet


Molecular Formula

C24H30O6

Molecular Weight

414.5 g/mol

CAS Number

107724-20-9

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Slightly soluble

Purity

Purity information is available upon request (COA).

Synonym

Eplerenone; Inspra; 107724-20-9; SC-66110; (+)-Eplerenone

IUPAC/Chemical Name

methyl (1R,2S,9R,10R,11S,14R,15S,17R)-2,15-dimethyl-5,5'-dioxospiro[18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadec-6-ene-14,2'-oxolane]-9-carboxylate

InChl Key

JUKPWJGBANNWMW-VWBFHTRKSA-N

InChl Code

InChI=1S/C24H30O6/c1-21-7-4-14(25)10-13(21)11-15(20(27)28-3)19-16-5-8-23(9-6-18(26)30-23)22(16,2)12-17-24(19,21)29-17/h10,15-17,19H,4-9,11-12H2,1-3H3/t15-,16+,17-,19+,21+,22+,23-,24-/m1/s1

References

https://pubchem.ncbi.nlm.nih.gov/compound/443872;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download